149 related articles for article (PubMed ID: 9722198)
1. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period.
Bortolotti F; Jara P; Crivellaro C; Hierro L; Cadrobbi P; Frauca E; Camarena C; De La Vega A; Diaz C; De Moliner L; Noventa F
J Hepatol; 1998 Aug; 29(2):184-90. PubMed ID: 9722198
[TBL] [Abstract][Full Text] [Related]
2. The long-term course of chronic hepatitis B.
Di Marco V; Lo Iacono O; Cammà C; Vaccaro A; Giunta M; Martorana G; Fuschi P; Almasio PL; Craxì A
Hepatology; 1999 Jul; 30(1):257-64. PubMed ID: 10385664
[TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study.
Bortolotti F; Guido M; Bartolacci S; Cadrobbi P; Crivellaro C; Noventa F; Morsica G; Moriondo M; Gatta A
Hepatology; 2006 Mar; 43(3):556-62. PubMed ID: 16496323
[TBL] [Abstract][Full Text] [Related]
4. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.
McMahon BJ; Holck P; Bulkow L; Snowball M
Ann Intern Med; 2001 Nov; 135(9):759-68. PubMed ID: 11694101
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
Hsu YS; Chien RN; Yeh CT; Sheen IS; Chiou HY; Chu CM; Liaw YF
Hepatology; 2002 Jun; 35(6):1522-7. PubMed ID: 12029639
[TBL] [Abstract][Full Text] [Related]
6. The long-term evolution of chronic hepatitis B acquired in childhood.
Manzat Saplacan RM; Mircea PA; Valean SD; Miu N; Burac L; Valean C; Nanulescu M
J Gastrointestin Liver Dis; 2009 Dec; 18(4):433-8. PubMed ID: 20076815
[TBL] [Abstract][Full Text] [Related]
7. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age.
Chang MH; Hsu HY; Hsu HC; Ni YH; Chen JS; Chen DS
Hepatology; 1995 Nov; 22(5):1387-92. PubMed ID: 7590652
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of chronic hepatitis B in adolescents or young adults in follow-up from childhood.
Fujisawa T; Komatsu H; Inui A; Sogo T; Miyagawa Y; Fujitsuka S; Sekine I; Kosugi T; Inui M
J Pediatr Gastroenterol Nutr; 2000 Feb; 30(2):201-6. PubMed ID: 10697141
[TBL] [Abstract][Full Text] [Related]
9. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Liaw YF; Chu CM; Lin DY; Sheen IS; Yang CY; Huang MJ
J Med Virol; 1984; 13(4):385-91. PubMed ID: 6330293
[TBL] [Abstract][Full Text] [Related]
10. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
[TBL] [Abstract][Full Text] [Related]
11. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
Chu CM
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
[TBL] [Abstract][Full Text] [Related]
13. Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy.
Ieluzzi D; Covolo L; Donato F; Fattovich G
Dig Liver Dis; 2014 May; 46(5):427-32. PubMed ID: 24548819
[TBL] [Abstract][Full Text] [Related]
14. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis.
Tseng TC; Liu CJ; Chang CT; Su TH; Yang WT; Tsai CH; Chen CL; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
J Hepatol; 2020 Jun; 72(6):1105-1111. PubMed ID: 32006586
[TBL] [Abstract][Full Text] [Related]
15. Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Māori: results from a 28-year follow-up study.
Lim TH; Gane E; Moyes C; Borman B; Cunningham C
Gut; 2015 Jun; 64(6):966-72. PubMed ID: 25006011
[TBL] [Abstract][Full Text] [Related]
16. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
Lok AS; Perrillo R; Lalama CM; Fried MW; Belle SH; Ghany MG; Khalili M; Fontana RJ; Sterling RK; Terrault N; Feld JJ; Di Bisceglie AM; Lau DTY; Hassan M; Janssen HLA;
Hepatology; 2021 Jun; 73(6):2124-2140. PubMed ID: 32936969
[TBL] [Abstract][Full Text] [Related]
17. [A randomized controlled study on factors influencing the curative effect of sequential combined interferon and lamivudine therapy in children with immune-tolerant phase chronic hepatitis B].
Zhu SS; Dong Y; Zhang HF; Wang LM; Xu ZQ; Zhang M; Gan Y; Chen DW; Wang FC; Yan JG; Zhao P
Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):604-609. PubMed ID: 31594077
[No Abstract] [Full Text] [Related]
18. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
Fattovich G; Rugge M; Brollo L; Pontisso P; Noventa F; Guido M; Alberti A; Realdi G
Hepatology; 1986; 6(2):167-72. PubMed ID: 3957228
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome in children with chronic hepatitis B: a 24-year observation period.
Iorio R; Giannattasio A; Cirillo F; D' Alessandro L; Vegnente A
Clin Infect Dis; 2007 Oct; 45(8):943-9. PubMed ID: 17879906
[TBL] [Abstract][Full Text] [Related]
20. HBeAg seroconversion in children infected during early childhood with hepatitis B virus.
Roushan MR; Bijani A; Ramzaninejad S; Roushan MH; Amiri MJ; Baiani M
J Clin Virol; 2012 Sep; 55(1):30-3. PubMed ID: 22727680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
